Mar 7, 2018 | Behavioral, Drugs, Products, Substance Abuse
As part of an initiative to expand access to medication-assisted treatment (MAT), the FDA plans to allow drug companies to sell medications that do not completely stop addiction but rather help alleviate cravings. The agency will put forth guidance and recommendations later this month. This move to expand access reflects the ongoing support for MAT.Click to read more.
